These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1973552)

  • 21. Malignant hyperthermia.
    Byers DJ; Krishna G
    Semin Pediatr Surg; 1992 Feb; 1(1):88-95. PubMed ID: 1345475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing?
    Robinson RL; Anetseder MJ; Brancadoro V; van Broekhoven C; Carsana A; Censier K; Fortunato G; Girard T; Heytens L; Hopkins PM; Jurkat-Rott K; Klinger W; Kozak-Ribbens G; Krivosic R; Monnier N; Nivoche Y; Olthoff D; Rueffert H; Sorrentino V; Tegazzin V; Mueller CR
    Eur J Hum Genet; 2003 Apr; 11(4):342-8. PubMed ID: 12700608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic mapping of the beta 1- and gamma-subunits of the human skeletal muscle L-type voltage-dependent calcium channel on chromosome 17q and exclusion as candidate genes for malignant hyperthermia susceptibility.
    Iles DE; Segers B; Sengers RC; Monsieurs K; Heytens L; Halsall PJ; Hopkins PM; Ellis FR; Hall-Curran JL; Stewart AD
    Hum Mol Genet; 1993 Jul; 2(7):863-8. PubMed ID: 8395940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cosmid and yeast artificial chromosome contig containing the complete ryanodine receptor (RYR1) gene.
    Rouquier S; Giorgi D; Trask B; Bergmann A; Phillips MS; MacLennan DH; de Jong P
    Genomics; 1993 Aug; 17(2):330-40. PubMed ID: 8406483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AANA Journal course: update for nurse anesthetists--genetic testing for malignant hyperthermia.
    Curtis S
    AANA J; 1996 Dec; 64(6):557-62. PubMed ID: 9204791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The usefulness of three biallelic restriction fragment length polymorphisms versus a polymorphic dinucleotide tandem repeat polymorphism at the low-density-lipoprotein receptor gene locus for diagnosis of familial hypercholesterolemia.
    Weiss N; Gudnasson V; Ostwald P; Humphries S; Schuster H; Keller C
    Dis Markers; 1997 Nov; 13(3):141-51. PubMed ID: 9405927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for the localization of a malignant hyperthermia susceptibility locus (MHS2) to human chromosome 17q.
    Levitt RC; Olckers A; Meyers S; Fletcher JE; Rosenberg H; Isaacs H; Meyers DA
    Genomics; 1992 Nov; 14(3):562-6. PubMed ID: 1427885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotype assignment of haemophilia A by use of intragenic and extragenic restriction fragment length polymorphisms.
    Bröcker-Vriends AH; Briët E; Quadt R; Dreesen JC; Bakker E; Claassen-Tegelaar R; Kanhai HH; van de Kamp JJ; Pearson PL
    Thromb Haemost; 1987 Apr; 57(2):131-6. PubMed ID: 2885943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amplified fragment length polymorphism analysis on D5S436 locus and its application to linkage analysis in gene diagnosis of asthma.
    Huang K; Weng X; Liu J; Zhu Z; Xiao B; Yan M; Zhang H; Wang C
    Chin Med J (Engl); 1999 Feb; 112(2):112-4. PubMed ID: 11593573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A linkage study of malignant hyperthermia (MH).
    Bender K; Senff H; Wienker TF; Spiess-Kiefer C; Lehmann-Horn F
    Clin Genet; 1990 Mar; 37(3):221-5. PubMed ID: 2323092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
    McCarthy TV; Quane KA; Lynch PJ
    Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-q13.2.
    Healy JM; Lehane M; Heffron JJ; Farrell M; Johnson K; McCarthy TV
    Biochem Soc Trans; 1990 Apr; 18(2):326. PubMed ID: 2379741
    [No Abstract]   [Full Text] [Related]  

  • 33. Prenatal diagnosis of Friedreich ataxia.
    Wallis J; Shaw J; Wilkes D; Farrall M; Williamson R; Chamberlain S; Skare JC; Milunsky A
    Am J Med Genet; 1989 Nov; 34(3):458-61. PubMed ID: 2574535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refined genetic localization for central core disease.
    Mulley JC; Kozman HM; Phillips HA; Gedeon AK; McCure JA; Iles DE; Gregg RG; Hogan K; Couch FJ; MacLennan DH
    Am J Hum Genet; 1993 Feb; 52(2):398-405. PubMed ID: 8430700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The genetics of malignant hyperthermia.
    Ball SP; Johnson KJ
    J Med Genet; 1993 Feb; 30(2):89-93. PubMed ID: 8383206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discordance between phenotype and genotype in malignant hyperthermia.
    MacLennan DH
    Curr Opin Neurol; 1995 Oct; 8(5):397-401. PubMed ID: 8542047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant hyperthermia and central core disease: analysis of two families with heterogeneous clinical expression.
    Romero NB; Nivoche Y; Lunardi J; Bruneau B; Cheval MA; Hillaire D; Fardeau M
    Neuromuscul Disord; 1993; 3(5-6):547-51. PubMed ID: 8186709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospects for the diagnosis of malignant hyperthermia susceptibility using molecular genetic approaches.
    Levitt RC
    Anesthesiology; 1992 Jun; 76(6):1039-48. PubMed ID: 1599089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detecting susceptibility to malignant hyperthermia.
    Ellis FR
    BMJ; 1992 Mar; 304(6830):791-2. PubMed ID: 1392703
    [No Abstract]   [Full Text] [Related]  

  • 40. [Molecular genetic tests are not yet useful for diagnosis of malignant hyperthermia].
    Ranklev-Twetman E; Isander G; Fletcher R
    Lakartidningen; 1992 May; 89(21):1869. PubMed ID: 1598048
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.